Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 75
SponsorTang-Du Hospital

About this trial

This study is a prospective, randomized, controlled study, which intends to enroll patients with suspected early-stage NSCLC (non-small cell lung cancer) with a diameter of ≤ 3 cm as research subjects. The study is conducted in accordance with the Declaration of Helsinki. It has been approved by the Ethics Committee of the Second Affiliated Hospital of Air Force Medical University, and patients or their family members have signed the informed consent form. Patients undergoing VATS (video-assisted thoracic surgery) are enrolled in the Department of Thoracic Surgery of the Second Affiliated Hospital of Air Force Medical University. The patients are randomly divided into two groups: the NIVATS (non-intubated video-assisted thoracic surgery) group and the OLV (one-lung ventilation) group. By observing various perioperative indicators of the patients, the short-term efficacy of the two techniques in patients with early-stage NSCLC is compared, so as to evaluate the safety and effectiveness of the NIVATS surgical treatment method.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≤ 75 years;

Gender is not limited;

Patients with suspected T1 stage non-small cell lung cancer (NSCLC) in preoperative clinical staging, with thin-slice CT showing that the maximum tumor diameter is ≤ 3.0 cm, single or multiple nodules, and the nodules requiring surgical resection are located in the same ipsilateral lung lobe, with the number of nodules resected simultaneously ≤ 3;

American Society of Anesthesiologists (ASA) classification ≤ Grade III (preferably Grade I - II is recommended);

Disqualifiers

A history of ipsilateral lung surgery;

Interstitial pneumonia, pulmonary fibrosis, severe emphysema, severe chronic obstructive pulmonary disease, acute phase of pulmonary infection, or uncontrolled asthma;

Sleep apnea syndrome with anticipated airway difficulty or difficulty in airway management;

Preoperative complications including coagulation dysfunction, hypoxemia, hypercapnia, or hepatic/renal insufficiency;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Non-intubated video-assisted thoracic surgery with spontaneous breathing (NIVATS)

    Procedure/Surgery

    NIVATS is a special method developed in the past two decades. It means that patients do not undergo tracheal intubation under general anesthesia during the entire surgical process, retaining their spontaneous breathing, but supraglottic airway devices (such as laryngeal masks, high-flow nasal catheters, mask ventilation) can be used to support their breathing. The purpose of this technology is to minimize the impact of general anesthesia, tracheal intubation, mechanical ventilation, etc. on patients.

Treatment groups

410 Participants
are divided into 2 treatment groups
Group A: group AExperimental treatment 1 intervention
Group B: group BPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Average postoperative hospital stay

Time frame
up to 3 months
2

Intraoperative opioid consumption

Time frame
1 day

Secondary outcomes

1

Lung collapse score

Time frame
1 day
2

Intraoperative blood gas analysis (Q1h)

Time frame
1 day
3

Conversion to intubation rate

Time frame
1 day
4

Postoperative awakening time

Time frame
1 day

Other outcomes

1

The impact of nursing education on discharge time and time to first ambulation after surgery

Time frame
up to 3 months
2

Comparison of the effects of thoracic paravertebral nerve block and intrathoracic intercostal nerve block

Time frame
up to 3 months
3

1-, 3-, and 5-year disease-free survival (DFS)

Time frame
up to 5 years
4

1-, 3-, 5-, and 10-year overall survival (OS)

Time frame
up to 10 years

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: